331 related articles for article (PubMed ID: 20421480)
1. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
2. Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs.
Takeyama N; Yuki Y; Tokuhara D; Oroku K; Mejima M; Kurokawa S; Kuroda M; Kodama T; Nagai S; Ueda S; Kiyono H
Vaccine; 2015 Sep; 33(39):5204-11. PubMed ID: 26254309
[TBL] [Abstract][Full Text] [Related]
3. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
4. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
5. Significance of Enterotoxigenic Escherichia coli (ETEC) Heat-Labile Toxin (LT) Enzymatic Subunit Epitopes in LT Enterotoxicity and Immunogenicity.
Huang J; Duan Q; Zhang W
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29802193
[TBL] [Abstract][Full Text] [Related]
6. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
8. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants.
Kashima K; Yuki Y; Mejima M; Kurokawa S; Suzuki Y; Minakawa S; Takeyama N; Fukuyama Y; Azegami T; Tanimoto T; Kuroda M; Tamura M; Gomi Y; Kiyono H
Plant Cell Rep; 2016 Mar; 35(3):667-79. PubMed ID: 26661780
[TBL] [Abstract][Full Text] [Related]
9. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Neogy PK; Stanton B; Huda N; Khan MU; Kay BA; Khan MR
J Infect Dis; 1988 Aug; 158(2):372-7. PubMed ID: 3042876
[TBL] [Abstract][Full Text] [Related]
10. Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Yuki Y; Nojima M; Kashima K; Sugiura K; Maruyama S; Kurokawa S; Yamanoue T; Nakahashi-Ouchida R; Nakajima H; Hiraizumi T; Kohno H; Goto E; Fujihashi K; Kiyono H
Vaccine; 2022 May; 40(24):3372-3379. PubMed ID: 35484039
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
[TBL] [Abstract][Full Text] [Related]
14. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
Svennerholm AM
Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
[TBL] [Abstract][Full Text] [Related]
15. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
Jelinek T; Kollaritsch H
Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
[TBL] [Abstract][Full Text] [Related]
18. Studies on formulation of a combination heat killed immunogen from diarrheagenic Escherichia coli and Vibrio cholerae in RITARD model.
Mukherjee P; Mondal V; Bhaumik U; Sinha R; Sarkar S; Mitra S; Howlader DR; Maiti S; Mukhopadhyay AK; Dutta S; Koley H
Microbes Infect; 2019; 21(8-9):368-376. PubMed ID: 30853357
[TBL] [Abstract][Full Text] [Related]
19. Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic
Hui Xian T; Parasuraman S; Ravichandran M; Prabhakaran G
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560571
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins.
Kazemi R; Akhavian A; Amani J; Salimian J; Motamedi MJ; Mousavi A; Jafari M; Salmanian AH
Microbes Infect; 2016 Jun; 18(6):421-429. PubMed ID: 26970204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
